ABX-CRO INC.
Moritz Kallerhoff is the current Chief Executive Officer at ABX-CRO INC. and the Chief Business Development Officer at PharmAI GmbH. With an MBA from Pfeiffer University and a Diploma in Business Administration from the University of Applied Sciences, Nuremberg, Moritz has a strong background in business development and management. Prior to his current roles, Moritz has held positions such as Director of Business Development and Senior Contracts & Proposals Manager in various companies within the pharmaceutical and electronics industries.
This person is not in any teams
ABX-CRO INC.
Your full-service Contract Research Organization (CRO) with emphasis on oncology and neurology indications with imaging endpoints including dosimetry services. We are headquartered in Boston, MA and can support your trial from early stage phase I studies all the way to global phase III studies. With an unique approach to trial design and trial conduct we offer a solution for pharmaceutical and biotech companies with support from a multi-disciplinary team able to bring your product from bench to bedside. Find out what makes us unique and talk to us. We are happy to assist you in your development pipeline.